This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
The product has been in-licensed from Strides and will be commercialized by Amneal
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
_256_384.jpg)
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Subscribe To Our Newsletter & Stay Updated
